- 27,889 additions to the chemical inventory
- 3,429 additions to the inventory of uncertified chemical hypotheses
- Updated general acceptance scores reflecting the most recent developments in the peer-reviewed scientific literature
Major increase in ChemMeta's chemical inventory
In July 2018, we launched the commercial version of ChemMeta summarizing the scientific evidence investigating 1,838 chemicals and 2,646 hypotheses of bodily injury. By the end of 2019, that inventory had grown to 3,532 chemicals spanning 6,965 hypotheses. This release significantly increases the ChemMeta inventory to 31,493 chemicals and 10,241 hypotheses.*
The ChemMeta inventory now includes all chemical substances tagged with a CAS number by the National Library of Medicine. Most of these newly added chemicals (25,840) currently have "no relevant literature," meaning that ChemMeta's algorithms have not identified any relevant peer-reviewed published scientific studies investigating hypotheses of bodily injury.
But more than 2,100 newly added chemicals report general acceptance scores for one or more "uncertified" hypotheses. Uncertified hypotheses are hypotheses that ChemMeta's algorithms indicate may have been tested in the peer-reviewed literature, but have yet to be "certified" by a human analyst. The specific studies investigating these uncertified hypotheses (more than 232,000 in all) can be accessed via individual chemical pages by clicking on the general acceptance score for the hypothesis.
We have more work to do before we can say that ChemMeta addresses every chemical in commerce investigated for its potential to cause bodily injury, but this release gets us much closer. Stay tuned for major updates to ChemMeta's chemical inventory later this year including:
- Food additives
- Dietary supplements
- Chemicals not tagged with a CAS number by the National Library of Medicine
*ChemMeta's inventory of 1,574 active pharmaceutical ingredients has grown comparatively little since its release in September 2018. That inventory encompasses all APIs approved for marketing in the United States.